KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to 0.2.

  • Gsk's FCF Payout Ratio rose 4601.03% to 0.2 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.25, marking a year-over-year decrease of 767.18%. This contributed to the annual value of 0.25 for FY2025, which is 560.04% up from last year.
  • As of Q4 2025, Gsk's FCF Payout Ratio stood at 0.2, which was up 4601.03% from 0.23 recorded in Q3 2025.
  • In the past 5 years, Gsk's FCF Payout Ratio registered a high of 0.02 during Q3 2023, and its lowest value of 1.38 during Q1 2021.
  • In the last 5 years, Gsk's FCF Payout Ratio had a median value of 0.24 in 2025 and averaged 0.35.
  • In the last 5 years, Gsk's FCF Payout Ratio tumbled by 117001.06% in 2022 and then surged by 8773.48% in 2023.
  • Gsk's FCF Payout Ratio (Quarter) stood at 0.09 in 2021, then tumbled by 689.08% to 0.73 in 2022, then surged by 37.72% to 0.46 in 2023, then grew by 19.65% to 0.37 in 2024, then skyrocketed by 46.01% to 0.2 in 2025.
  • Its FCF Payout Ratio was 0.2 in Q4 2025, compared to 0.23 in Q3 2025 and 0.24 in Q2 2025.